Vita Life Sciences Limited (VLS.AX)
AUD 1.77
(-1.67%)
AUD 1.77
(-1.67%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 13.09 Million AUD | 11.93% |
| 2022 | 11.37 Million AUD | -2.94% |
| 2021 | 11.71 Million AUD | 31.97% |
| 2020 | 8.87 Million AUD | 71.44% |
| 2019 | 5.15 Million AUD | 7.16% |
| 2018 | 4.83 Million AUD | -6.16% |
| 2017 | 5.14 Million AUD | -15.19% |
| 2016 | 6.05 Million AUD | -4.75% |
| 2015 | 6.37 Million AUD | -11.19% |
| 2014 | 7.17 Million AUD | 24.49% |
| 2013 | 5.64 Million AUD | 86.81% |
| 2012 | 3 Million AUD | 84.42% |
| 2011 | 1.66 Million AUD | -66.48% |
| 2010 | 4.97 Million AUD | 63747.93% |
| 2009 | -11.01 Thousand AUD | -101.2% |
| 2008 | 779.72 Thousand AUD | 164.32% |
| 2007 | 429.75 Thousand AUD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 5.68 Million AUD | 0.0% |
| 2023 Q2 | 5.76 Million AUD | 0.0% |
| 2023 Q4 | 6.96 Million AUD | 0.0% |
| 2023 FY | - AUD | 11.93% |
| 2022 Q2 | 5.73 Million AUD | 0.0% |
| 2022 Q4 | 5.89 Million AUD | 0.0% |
| 2022 FY | - AUD | -2.94% |
| 2021 Q4 | 6.51 Million AUD | 0.0% |
| 2021 FY | - AUD | 31.97% |
| 2021 Q2 | 5.15 Million AUD | 0.0% |
| 2020 Q2 | 4.41 Million AUD | 0.0% |
| 2020 Q4 | 3.68 Million AUD | 0.0% |
| 2020 FY | - AUD | 71.44% |
| 2019 FY | - AUD | 7.16% |
| 2019 Q4 | 3.15 Million AUD | 0.0% |
| 2019 Q2 | 1.55 Million AUD | 0.0% |
| 2018 Q2 | 2.95 Million AUD | 142.48% |
| 2018 Q1 | 1.21 Million AUD | -51.71% |
| 2018 Q4 | 3.51 Million AUD | 0.0% |
| 2018 FY | - AUD | -6.16% |
| 2017 Q4 | 2.52 Million AUD | 0.0% |
| 2017 Q1 | 1.28 Million AUD | -54.64% |
| 2017 FY | - AUD | -15.19% |
| 2017 Q2 | 2.49 Million AUD | 93.91% |
| 2016 Q2 | 3.05 Million AUD | 101.28% |
| 2016 Q1 | 1.51 Million AUD | -59.76% |
| 2016 FY | - AUD | -4.75% |
| 2016 Q4 | 2.84 Million AUD | 0.0% |
| 2015 Q4 | 3.77 Million AUD | 135.51% |
| 2015 FY | - AUD | -11.19% |
| 2015 Q2 | 2.41 Million AUD | 50.95% |
| 2015 Q1 | 1.6 Million AUD | -55.57% |
| 2015 Q3 | 1.6 Million AUD | -33.75% |
| 2014 Q3 | 1.79 Million AUD | -46.78% |
| 2014 Q2 | 3.36 Million AUD | 87.89% |
| 2014 Q1 | 1.79 Million AUD | -43.1% |
| 2014 FY | - AUD | 24.49% |
| 2014 Q4 | 3.6 Million AUD | 101.23% |
| 2013 Q1 | 1.43 Million AUD | 0.0% |
| 2013 Q4 | 3.15 Million AUD | 119.09% |
| 2013 Q3 | 1.43 Million AUD | -44.4% |
| 2013 Q2 | 2.58 Million AUD | 79.86% |
| 2013 FY | - AUD | 86.81% |
| 2012 Q1 | 780.75 Thousand AUD | 0.0% |
| 2012 Q2 | 780.75 Thousand AUD | 0.0% |
| 2012 Q3 | 780.75 Thousand AUD | 0.0% |
| 2012 Q4 | 1.43 Million AUD | 84.15% |
| 2012 FY | - AUD | 84.42% |
| 2011 Q2 | 413.46 Thousand AUD | 0.0% |
| 2011 Q4 | 780.75 Thousand AUD | 88.83% |
| 2011 FY | - AUD | -66.48% |
| 2011 Q1 | 413.46 Thousand AUD | 0.0% |
| 2011 Q3 | 413.46 Thousand AUD | 0.0% |
| 2010 FY | - AUD | 63747.93% |
| 2010 Q4 | 413.46 Thousand AUD | -66.58% |
| 2010 Q3 | 1.23 Million AUD | 0.0% |
| 2010 Q2 | 1.23 Million AUD | 0.0% |
| 2010 Q1 | 1.23 Million AUD | 0.0% |
| 2009 Q2 | -2754.00 AUD | 0.0% |
| 2009 FY | - AUD | -101.2% |
| 2009 Q4 | 1.23 Million AUD | 45022.51% |
| 2009 Q3 | -2754.00 AUD | 0.0% |
| 2009 Q1 | -2754.00 AUD | 0.0% |
| 2008 Q2 | 148.47 Thousand AUD | 0.0% |
| 2008 Q4 | -2754.00 AUD | -101.85% |
| 2008 Q1 | 148.47 Thousand AUD | 0.0% |
| 2008 FY | - AUD | 164.32% |
| 2008 Q3 | 148.47 Thousand AUD | 0.0% |
| 2007 Q4 | 148.47 Thousand AUD | 419.39% |
| 2007 FY | - AUD | 0.0% |
| 2007 Q3 | 28.58 Thousand AUD | 0.0% |
| 2007 Q1 | 28.58 Thousand AUD | 0.0% |
| 2007 Q2 | 28.58 Thousand AUD | 0.0% |
| 2006 Q4 | 28.58 Thousand AUD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Althea Group Holdings Limited | -28.56 Million AUD | 145.86% |
| Cann Group Limited | -35.53 Million AUD | 136.858% |
| ECS Botanics Holdings Ltd | 3.22 Million AUD | -305.725% |
| Ecofibre Limited | -38.34 Million AUD | 134.159% |
| Elixinol Wellness Limited | -6.8 Million AUD | 292.448% |
| Hygrovest Limited | -1.1 Million AUD | 1287.489% |
| IDT Australia Limited | -5.13 Million AUD | 355.172% |
| Invion Limited | -4.57 Million AUD | 386.498% |
| Little Green Pharma Ltd | -4.64 Million AUD | 382.083% |
| Live Verdure Ltd | -12.51 Million AUD | 204.688% |
| Medical Developments International Limited | -29.44 Million AUD | 144.481% |
| Vitura Health Limited | 7.07 Million AUD | -85.098% |